HedgeChatter

NeoGenomics Reports Record Revenue of $18.3 Million, Adjusted EBITDA of $2.7 Million and Net Income of $0.02 per Share for the Fourth Quarter 2013

19 Feb

NeoGenomics Reports Record Revenue of $18.3 Million, Adjusted EBITDA of $2.7 Million and Net Income of $0.02 per Share for the Fourth Quarter 2013

Bystocknews , Comments Off on NeoGenomics Reports Record Revenue of $18.3 Million, Adjusted EBITDA of $2.7 Million and Net Income of $0.02 per Share for the Fourth Quarter 2013

[PR Newswire] – FT. MEYERS, Fla., Feb. 19, 2014 /PRNewswire/ — NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services today reported its results for the fourth quarter and full … more

View todays social media effects on NEO

View the latest stocks trending across Twitter. Click to view dashboard

See who NeoGenomics is hiring next, click here to view

Share this post

Author

stocknews